phrykt

Accendra Health Inc/Va/ (ACH): who owns it and who trades it

As of Nov 16, 2026, no open-market insider purchases or sales of ACH were reported in the last 12 months. 4 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Accendra Health

From the latest filings

Overall: about as much buying as selling. Funds and famous investors were close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns ACH

138 funds and institutions reported ACH shares worth $223M at the end of Q2 2026, about 85% of the company. The largest holder is Coliseum Capital Management, LLC with 17.0%.

Funds and institutions (13F) 85%Everyone else 15%

10 largest owners, by share of the company

Coliseum Capital Management, LLC17.0%
BlackRock, Inc.7.2%
Bank of America Corp4.9%
Vanguard Capital Management LLC4.0%
D. E. Shaw & Co., Inc.4.0%
Charles Schwab Investment Management Inc3.8%
Sixth Street Partners Management Company, L.P.3.8%
Invenomic Capital Management LP3.7%
Marshall Wace, LLP3.4%
Paradigm Capital Management Inc3.3%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
Coliseum Capital Management, LLC13.10M17.04%$44.8MNo change
BlackRock, Inc.5.50M7.16%$18.8M+5%
Bank of America Corp3.78M4.91%$12.9M+11%
Vanguard Capital Management LLC3.09M4.02%$10.6M-6%
D. E. Shaw & Co., Inc.3.08M4.01%$10.5M-7%
Charles Schwab Investment Management Inc2.89M3.76%$9.9M-21%
Sixth Street Partners Management Company, L.P.2.89M3.76%$9.9M–
Invenomic Capital Management LP2.81M3.66%$9.6M-17%
Marshall Wace, LLP2.58M3.36%$8.8M+47%
Paradigm Capital Management Inc2.54M3.30%$8.7M+42%
Vanguard Portfolio Management LLC2.03M2.64%$6.9M-23%
Dana Investment Advisors, Inc.1.94M2.53%$6.7M+31%
Geode Capital Management, LLC1.87M2.44%$6.4M+2%
Dimensional Fund Advisors LP1.64M2.13%$5.6M-37%
State Street Corp1.60M2.08%$5.5M-2%
Connor, Clark & Lunn Investment Management Ltd.1.29M1.68%$4.4M-7%
AQR Capital Management LLC1.07M1.39%$3.7M+46%
Goldman Sachs Group Inc854,7301.11%$2.9M-9%
Acadian Asset Management LLC820,0701.07%$2.8M-10%
Two Sigma Investments, LP718,5500.93%$2.5M-40%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

No ACH insider reported an open-market purchase or sale in the last 12 months.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$0
0 trades, 0 people
Sales under a 10b5-1 plan
–
Share of sale value
Latest trade
–
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

ACH short interest

High short interest. 13.2% of ACH shares are sold short: about 1 share in 8. Over the last 12 reports the number of shares short went up 73%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 10.14M ACH shares were sold short, 13.2% of the shares outstanding, up 11.3% from the report before. At the average daily volume of 2.51M shares, buying them all back would take about 4.0 trading days (days to cover).

Shares short, % of all shares

13.2%May 15Oct 3014.1%

Days to cover

4.0May 15Oct 3014.1

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 202610.14M13.18%+11%2.51M4.0
Oct 15, 20269.11M11.84%+8%1.85M4.9
Sep 30, 20268.42M10.95%-5%1.73M4.9
Sep 15, 20268.90M11.57%+1%852,56110.4
Aug 31, 20268.83M11.48%+37%1.86M4.8
Aug 14, 20266.46M8.39%+21%2.49M2.6
Jul 31, 20265.33M6.92%-4%422,31812.6
Jul 15, 20265.57M7.24%-5%602,0349.2
Jun 30, 20265.86M7.62%-12%876,0186.7
Jun 15, 20266.64M8.67%+9%684,7079.7
May 29, 20266.07M7.92%+4%743,0948.2
May 15, 20265.85M7.63%-2%1.13M5.2

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Accendra Health company events

Accendra Health filed 22 reports on Form 8-K in the last 12 months, 10 of them about an important change (leadership, listing). The latest was on Nov 5, 2026.

  1. Nov 5, 2026ResultsReleased financial results. Filing
  2. Nov 3, 2026LeadershipPerry A. Bernocchi, the Company’s Executive Vice President, Chief Operating Officer, entered into a transition agreement with the Company under which Mr. Bernocchi will cease to be an executive officer and will serve as Strategic Advisor to the Chief Executive Officer until December 31, 2026… Filing
  3. Nov 2, 2026AgreementAccendra Funding LLC and Byram Healthcare Centers, Inc. each a wholly-owned subsidiary of Accendra Health, Inc., entered into the Third Amendment to the Amended & Restated Receivables Purchase Agreement, which amends that certain Amended & Restated Receivables Purchase Agreement, dated as of… Filing
  4. Oct 30, 2026ListingAccendra Health, Inc. received notice from the New York Stock Exchange that it was not in compliance with the continued listing standard set forth in Section 802.01B of the NYSE’s Listed Company Manual that the Company have an average market capitalization of not less than $50.0 million over a… Filing
  5. Oct 9, 2026ListingOn October 6, 2026 Accendra Health, Inc. received notice from the New York Stock Exchange that it was not in compliance with the continued listing standard set forth in Section 802.01C of the NYSE’s Listed Company Manual because the average closing price of the Company’s Common Stock was less than… Filing
  6. Sep 28, 2026LeadershipAmended an earlier report. To report that, on that date, Accendra Health announced that it named Kenneth Gardner-Smith as the Company’s next President and Chief Executive Officer. Filing
  7. Sep 17, 2026LeadershipAccendra Health, Inc. announced that it named Kenneth Gardner-Smith as the Company’s next President and Chief Executive Officer. Filing
  8. Aug 17, 2026AnnouncementShared information with investors. Filing
  9. Aug 10, 2026AgreementThe board of directors of Accendra Health, Inc. has taken actions to facilitate the Company’s ability to preserve its net operating losses and certain other tax attributes. Filing
  10. Aug 10, 2026ResultsReleased financial results. Filing
  11. Aug 10, 2026LeadershipAccendra Health, Inc. announced that Edward A. Pesicka, President, Chief Executive Officer & Director of the Company, notified the board of directors of the Company of his intention to retire and step down from the Board by the end of 2026, or such earlier time as a successor is appointed. Filing
  12. Jun 25, 2026AnnouncementThe Company issued a press release announcing the expiration and final results of the Exchange Offers and Consent Solicitations, which is filed hereto as Exhibit 99.1 and incorporated by reference herein. Filing
  13. Jun 15, 2026AgreementThe information set forth in the Explanatory Note of this Current Report on Form 8-K (this “Current Report”) is incorporated into this Item 1.01 by reference. Filing
  14. May 22, 2026AnnouncementShared information with investors. Filing
  15. May 15, 2026LeadershipOn May 14, 2026 at the 2026 Annual Meeting of Shareholders of Accendra Health, Inc., the shareholders approved the Accendra Health, Inc. Amended and Restated 2023 Omnibus Incentive Plan which amends and restates the Owens & Minor, Inc. 2023 Omnibus Incentive Plan (as amended as of March 14, 2024). Filing
  16. May 11, 2026AgreementAccendra Health, Inc. entered into a Commitment and Consent Letter with certain institutions that are (a)(i) holders of the Company’s 4.500% Senior Notes due 2029 and 6.625% Senior Notes due 2030 (the “ 2030 Notes ” and, together with the 2029 Notes, the “ Existing Notes ”), collectively holding… Filing
  17. May 11, 2026ResultsReleased financial results. Filing
  18. Feb 19, 2026ResultsReleased financial results. Filing
  19. Dec 31, 2025LeadershipDeparture of Andrew G. Long On the Closing Date, in connection with the Transactions, Andrew G. Long, Executive Vice President, Chief Executive Officer, Products & Healthcare Services, ceased to be an executive officer of the Company. Filing
  20. Dec 18, 2025LeadershipThe board of directors of Owens & Minor, Inc. approved an amendment to the Owens & Minor, Inc. Executive Deferred Compensation and Retirement Plan, to freeze participation and all contributions under the EDCRP for all participants, effective as of January 1, 2026. Filing
  21. Dec 8, 2025LeadershipDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers. Filing
  22. Dec 2, 2025AnnouncementShared information with investors. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Accendra Health financials

Famous investors that hold ACH

4 of the 50 well-known investors we track reported holding ACH in their latest 13F filing. The largest position is Ken Griffin's, worth $404K.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Ken Griffin · Citadel AdvisorsQ3 2026718,246$404K0.0%+86%
Paul Tudor Jones · Tudor Investment CorpQ3 2026638,471$359K0.0%+13%
Jim Simons · Renaissance TechnologiesQ3 2026315,213$177K0.0%-3%
Israel Englander · Millennium ManagementQ3 2026160,236$90.2K0.0%-21%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 4 filings named ACH in the last 120 days.

FiledHolderFormStake
Nov 12, 2026PARADIGM CAPITAL MANAGEMENT INC/NY13G5.1%
Nov 12, 2026PARADIGM CAPITAL MANAGEMENT INC/NY13G5.1%
Oct 7, 2026BANK OF AMERICA CORP /DE/13G10.8%
Oct 7, 2026BANK OF AMERICA CORP /DE/13G10.8%

Questions about Accendra Health Inc/Va/ (ACH) stock

Who owns the most ACH stock?

The largest reported owner of Accendra Health Inc/Va/ (ACH) is Coliseum Capital Management, LLC, with 17.0% of the company. In total, 138 funds and institutions reported holding ACH at the end of Q2 2026, together about 85% of the shares. See the largest owners.

Are ACH insiders buying or selling?

No ACH insider reported an open-market purchase or sale on Form 4 in the last 12 months. Share awards, option exercises and gifts are not counted.

What is the short interest in ACH?

As of Oct 30, 2026, 10.14M ACH shares were sold short, 13.2% of the shares outstanding, up 11.3% from the report before. At the average daily volume of 2.51M shares, buying them all back would take about 4.0 trading days (days to cover). See the history.

Which famous investors hold ACH?

4 of the 50 well-known investors we track reported ACH in their latest 13F filing, including Ken Griffin, Paul Tudor Jones, Jim Simons. The largest position is worth $404K. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.